Alex Aliper

How AI turbocharged the development of a new drug and what it might mean for health care fortune.com/2024/03/14/ins…

Big paper alert: TNIK inhibitor designed using generative AI targets fibrosis in preclinical and clinical trials nature.com/articles/s4158…

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models go.nature.com/3IvPOuI

Great news on Friday: the paper about our most advanced therapeutic program against Idiopathic Pulmonary Fibrosis just got published in Nature Biotechnology: nature.com/articles/s4158… Congratulations to the Team! 👏 @InSilicoMeds @biogerontology

No humans allowed: Alex Zhavoronkov adds robotic lab to his AI drug discovery play as Insilico unveils $60M raise - endpts.com/no-humans-allo…

New research published in Aging describes how ⁦@InSilicoMeds⁩ PandaOmics software was able to predict molecular targets for new drugs to Rx both aging & age-associated diseases like Alzheimer’s, Parkinson’s, cirrhosis, RA & more… #AI #pharma fiercebiotech.com/medtech/insili…

We just did something fun. Discovered a target without a structure, used AlphaFold-predicted structure for SBDD, got a weak hit in about 30 days. @A_Aspuru_Guzik @MLevitt_NP2013 #alphafold Check out and critique the pre-print as we wait for better hits arxiv.org/abs/2201.09647

Today @InSilicoMeds is thrilled to announce our most important news to date - our antifibrotic program has now progressed to the First-in-Human stage! prnewswire.com/news-releases/…

Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas prn.to/3lMx2oM

Today we are ready to reveal our new partner - Usynova Pharmaceuticals Ltd. Follow us to see another collaboration to be announced soon. @InSilicoMeds prnewswire.com/news-releases/…

Dear Friends, we have some exciting news! @InSilicoMeds just nominated a preclinical candidate (PCC) for kidney fibrosis, an age-related process implicated in multiple diseases. prnewswire.com/news-releases/…

We're always looking for new ways to accelerate innovation and help growers. Our partnership with @InSilicoMeds will unlock the transformative power of AI to make this happen. #AI4AG #AgTech #SyngentaCropProtection

We @InSilicoMeds are extremely proud to announce that the first fully AI-designed #drug candidate is entering the clinic! Both the biological #target and the molecules were discovered using #AI. For more info please watch our video documentary: youtu.be/AOJfkDu5nC4

Excited to announce our collaboration with @InSilicoMeds to use #artificialintelligence & deep learning to accelerate the invention of new, more sustainable products & technologies for growers: ai.syngenta.com #AI4Ag #SyngentaCropProtection

Very excited to announce our collaboration with Pfizer! xconomy.com/national/2020/…

@InSilicoMeds’ Dr Alex Zhavoronkov defines #Longevity The “MMA fighter” of Longevity talks business models, AI drug discovery & working with the right investors. longevity.technology @biogerontology #investment #AI #Juvenescence @sergeyyoung200 #Sinovation #MMA @gbpalantir

Celebrities tweet, superstar editors brief. Deeply honored to have our paper on deep generative model with @A_Aspuru_Guzik mentioned in @NatRevDrugDisc 🙏👩‍💻 nature.com/articles/d4157…